PUBLIC CONTRACT · 2021
Medicamentos Flucloxacilina Fosapepitant e Imunoglobulina Humana
- Contract value
- €8,157.00
- Signed on
- 6 December 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10807046PUBLISHED SUBJECT
41 5194/2021 - Medicamentos Flucloxacilina Fosapepitant e Imunoglobulina Humana
Parties involved
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- PT150 - Algarve
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- FRESENIUS KABI PHARMA PORTUGAL · Tax ID 504293753
- Awardee
- HIKMA FARMACÊUTICA (PORTUGAL) SA. · Tax ID 502266791
- Bidder
- GENERIS-FARMACEUTICA,SA · Tax ID 508107997
- Bidder
- TAKEDA - FARMACEUTICA PORTUGAL, LDA (ANTIGA NYCOMED) · Tax ID 502801204
- Bidder
- MERCK SHARP & DOHME, LDA · Tax ID 500191360
Values and timeline
- Contract price
- €8,157.00
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 5 July 2024
- Award date
- 6 December 2021
- Signing date
- 6 December 2021
- Performance period
- 30 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/55 - Medicamentos diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5664514
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.